TATA MOTORS PV

Launches Tata Punch In SA Starting At 2.24 Lk Rand

VARUN BEVERAGES:

Q2 VOLUME GROWTH OF 28.7% VS FY27 TARGETS DOUBLE-DIGIT VOLUME GROWTH

XCHANGING SOLUTIONS Q2 FY27 RESULTS (CONSOLIDATED)

• Net Profit: ₹15.19 Cr ↓6.58% (YoY) | ↑0.46% (QoQ)

• Revenue: ₹53.21 Cr ↑0.76% (YoY) | ↓0.80% (QoQ)

• EBITDA: ₹18.43 Cr ↑8.35% (YoY) | ↑2.45% (QoQ)

• EBITDA Margin: 34.64% vs 32.21% (YoY) | 33.54% (QoQ)

RESONANCE SPECIALTIES Q2 FY27 RESULTS (STANDALONE)

• Net Profit: ₹8 Cr ↑411% (YoY) | ↑47% (QoQ)

• Revenue: ₹34 Cr ↑59% (YoY) | ↑5% (QoQ)

• EBITDA: ₹11 Cr ↑362% (YoY) | ↑46% (QoQ)

• EBITDA Margin: 31.8% vs 11.0% (YoY) | 22.9% (QoQ)

GUJARAT CONTAINERS Q2 FY27 RESULTS

• Net Profit: ₹4.06 Cr ↑199.14% (YoY) | ↑7.92% (QoQ)

• Revenue: ₹44.47 Cr ↑21.30% (YoY) | ↓4.52% (QoQ)

• EBITDA: ₹6.03 Cr ↑132.24% (YoY) | ↑5.33% (QoQ)

• EBITDA Margin: 13.55% vs 7.08% (YoY) | 12.28% (QoQ)

WELSPUNLIV: Q2 CONS NET PROFIT 1.7B RUPEES VS 130M (YOY)

KIRLFER: Q2 SL NET PROFIT 976M RUPEES VS 885M (YOY)

KIRLFER: Q2 EBITDA 2.23B RUPEES VS 2.14B (YOY); Q2 EBITDA MARGIN 10.9% VS 12.36% (YOY)

KIRLFER: Q2 REVENUE 20.5B RUPEES VS 17.28B (YOY)

SHARDACROP: Q2 CONS NET PROFIT 918M RUPEES VS 743M (YOY)

SHARDACROP: Q2 EBITDA 1.64B RUPEES VS 1.33B (YOY); Q2 EBITDA MARGIN 15.6% VS 14.3% (YOY)


SHARDACROP: Q2 REVENUE 10.5B RUPEES VS 9.3B (YOY)

WELSPUNLIV: Q2 REVENUE 28.4B RUPEES VS 24.4B (YOY)

WELSPUNLIV: Q2 EBITDA 3.38B RUPEES VS 1.53B (YOY); Q2 EBITDA MARGIN 11.9% VS 6.3% (YOY)

SPORTKING: Q2 SL NET PROFIT 964M RUPEES VS 283M (YOY)

SPORTKING: Q2 REVENUE 7.8B RUPEES VS 6.3B (YOY)

SPORTKING: Q2 EBITDA 1.55B RUPEES VS 654M (YOY); Q2 EBITDA MARGIN 19.8% VS 10.4% (YOY)

TATA CHEMICALS, TATA INVESTMENT; Noel Tata Proposes Merging Tata Elec Sys & Tata Consulting Engineers Into Tata Sons - CNBC-TV18 🔴🔴

Noel Tata writes to Tata Sons board

Seeks 2 items on agenda for Nov 26 board meeting

TATA CHEMICALS, TATA INVESTMENT: NOEL Tata Aim Is To Cease Tata Sons Being An NBFC & A Core Investment Company - CNBC-TV18 🔴🔴

DHANUKA AGRITECH Q2 FY27 (STANDALONE) ; NET PROFIT UP 16% AT ₹109 CR (YOY), UP 201% (QOQ)

REVENUE UP 10% AT ₹658 CR (YOY), UP 42% (QOQ)

EBITDA UP 12% AT ₹153 CR (YOY), UP 178% (QOQ)

MARGINS AT 23.3% VS 22.9% (YOY), 11.9% (QOQ)

ABCAPITAL: Q2 CONS NET PROFIT 13B RUPEES VS 8.5B (YOY)

ABCAPITAL: Q2 REVENUE 140B RUPEES VS 106B (YOY)

ABCAPITAL: CO'S CONSOLIDATED REVENUE GREW BY 31% YOY TO ₹ 16,545 CRORE IN Q2 FY27

ADITYA BIRLA CAPITAL Q2 FY27 (CONS.) ; NET PROFIT UP 38% AT ₹1,288 CR (YOY), UP 10% (QOQ)

NII UP 28% AT ₹2,817 CR (YOY), UP 9% (QOQ)

INSURANCE PREMIUM UP 37 % TO 7198 CR YOY, UP 26 % QOQ

EMAMIPAP: Q2 SL NET PROFIT 444M RUPEES VS 66M (YOY)

EMAMIPAP: Q2 EBITDA 929M RUPEES VS 363M (YOY); Q2 EBITDA MARGIN 15.76% VS 8.1% (YOY)

SUNPHARMA: Q2 CONS PBT 44B RUPEES VS 42BB (YOY); CO HAS AN EXCEPTIONAL ITEM OF 12.7B RUPEES

SUNPHARMA: Q2 EBITDA 47.4B RUPEES VS 45.27B (YOY); Q2 EBITDA MARGIN 29.3% VS 31.27% (YOY)